Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Garvey

Showing results (81-90 of 122) with videos related to

Pageof 13
Sort By:
Journal of the American Academy of Dermatology|October 1, 1993
Complement polymorphism in herpes gestationis: association with C4 null alleleJ K Shornick, C M Artlett, R E Jenkins, et al.
Bioorganic & Medicinal Chemistry Letters|February 17, 2009
The use of oxadiazole and triazole substituted naphthyridines as HIV-1 integrase inhibitors. Part 1: Establishing the pharmacophoreBrian A Johns, Jason G Weatherhead, Scott H Allen, et al.
Bioorganic & Medicinal Chemistry Letters|February 17, 2009
1,3,4-Oxadiazole substituted naphthyridines as HIV-1 integrase inhibitors. Part 2: SAR of the C5 positionBrian A Johns, Jason G Weatherhead, Scott H Allen, et al.
The Journal of Biological Chemistry|October 28, 1994
Potent and selective inhibition of human nitric oxide synthases. Inhibition by non-amino acid isothioureasE P Garvey, J A Oplinger, G J Tanoury, et al.
Antimicrobial Agents and Chemotherapy|September 16, 2015
VT-1161 Protects Immunosuppressed Mice from Rhizopus arrhizus var. arrhizus InfectionTeclegiorgis Gebremariam, Nathan P Wiederhold, Annette W Fothergill, et al.
Antimicrobial Agents and Chemotherapy|August 7, 2019
Impact of the Major Candida glabrata Triazole Resistance Determinants on the Activity of the Novel Investigational Tetrazoles VT-1598 and VT-1161Andrew T Nishimoto, Sarah G Whaley, Nathan P Wiederhold, et al.
Antimicrobial Agents and Chemotherapy|June 28, 2017
Prophylactic Treatment with VT-1161 Protects Immunosuppressed Mice from Rhizopus arrhizus var. arrhizus InfectionTeclegiorgis Gebremariam, Sondus Alkhazraji, Lin Lin, et al.
The Journal of Biological Chemistry|October 28, 1994
Potent and selective inhibition of human nitric oxide synthases. Selective inhibition of neuronal nitric oxide synthase by S-methyl-L-thiocitrulline and S-ethyl-L-thiocitrullineE S Furfine, M F Harmon, J E Paith, et al.
Antimicrobial Agents and Chemotherapy|May 11, 2016
The Investigational Drug VT-1129 Is a Highly Potent Inhibitor of Cryptococcus Species CYP51 but Only Weakly Inhibits the Human EnzymeAndrew G S Warrilow, Josie E Parker, Claire L Price, et al.
Bioorganic & Medicinal Chemistry Letters|December 19, 2012
Naphthyridinone (NTD) integrase inhibitors: N1 protio and methyl combination substituent effects with C3 amide groupsBrian A Johns, Takashi Kawasuji, Jason G Weatherhead, et al.
Pageof 13

Showing results (81-90 of 122) with videos related to

Sort By:
Pageof 13
Journal of the American Academy of Dermatology|October 1, 1993
Complement polymorphism in herpes gestationis: association with C4 null alleleJ K Shornick, C M Artlett, R E Jenkins, et al.
Bioorganic & Medicinal Chemistry Letters|February 17, 2009
The use of oxadiazole and triazole substituted naphthyridines as HIV-1 integrase inhibitors. Part 1: Establishing the pharmacophoreBrian A Johns, Jason G Weatherhead, Scott H Allen, et al.
Bioorganic & Medicinal Chemistry Letters|February 17, 2009
1,3,4-Oxadiazole substituted naphthyridines as HIV-1 integrase inhibitors. Part 2: SAR of the C5 positionBrian A Johns, Jason G Weatherhead, Scott H Allen, et al.
The Journal of Biological Chemistry|October 28, 1994
Potent and selective inhibition of human nitric oxide synthases. Inhibition by non-amino acid isothioureasE P Garvey, J A Oplinger, G J Tanoury, et al.
Antimicrobial Agents and Chemotherapy|September 16, 2015
VT-1161 Protects Immunosuppressed Mice from Rhizopus arrhizus var. arrhizus InfectionTeclegiorgis Gebremariam, Nathan P Wiederhold, Annette W Fothergill, et al.
Antimicrobial Agents and Chemotherapy|August 7, 2019
Impact of the Major Candida glabrata Triazole Resistance Determinants on the Activity of the Novel Investigational Tetrazoles VT-1598 and VT-1161Andrew T Nishimoto, Sarah G Whaley, Nathan P Wiederhold, et al.
Antimicrobial Agents and Chemotherapy|June 28, 2017
Prophylactic Treatment with VT-1161 Protects Immunosuppressed Mice from Rhizopus arrhizus var. arrhizus InfectionTeclegiorgis Gebremariam, Sondus Alkhazraji, Lin Lin, et al.
The Journal of Biological Chemistry|October 28, 1994
Potent and selective inhibition of human nitric oxide synthases. Selective inhibition of neuronal nitric oxide synthase by S-methyl-L-thiocitrulline and S-ethyl-L-thiocitrullineE S Furfine, M F Harmon, J E Paith, et al.
Antimicrobial Agents and Chemotherapy|May 11, 2016
The Investigational Drug VT-1129 Is a Highly Potent Inhibitor of Cryptococcus Species CYP51 but Only Weakly Inhibits the Human EnzymeAndrew G S Warrilow, Josie E Parker, Claire L Price, et al.
Bioorganic & Medicinal Chemistry Letters|December 19, 2012
Naphthyridinone (NTD) integrase inhibitors: N1 protio and methyl combination substituent effects with C3 amide groupsBrian A Johns, Takashi Kawasuji, Jason G Weatherhead, et al.
Pageof 13